Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2017 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Heparin antagonizes cisplatin resistance of A2780 ovarian cancer cells by affecting the Wnt signaling pathway.
Oncotarget. 2017 Jun 28;8(40):67553-67566. doi: 10.18632/oncotarget.18738. eCollection 2017 Sep 15.
Oncotarget. 2017.
PMID: 28978053
Free PMC article.
The Impact of the Low Molecular Weight Heparin Tinzaparin on the Sensitization of Cisplatin-Resistant Ovarian Cancers-Preclinical In Vivo Evaluation in Xenograft Tumor Models.
Mueller T, Pfankuchen DB, Wantoch von Rekowski K, Schlesinger M, Reipsch F, Bendas G.
Mueller T, et al. Among authors: pfankuchen db.
Molecules. 2017 May 3;22(5):728. doi: 10.3390/molecules22050728.
Molecules. 2017.
PMID: 28467373
Free PMC article.
Item in Clipboard
Low molecular weight heparin tinzaparin antagonizes cisplatin resistance of ovarian cancer cells.
Pfankuchen DB, Stölting DP, Schlesinger M, Royer HD, Bendas G.
Pfankuchen DB, et al.
Biochem Pharmacol. 2015 Sep 15;97(2):147-57. doi: 10.1016/j.bcp.2015.07.013. Epub 2015 Jul 31.
Biochem Pharmacol. 2015.
PMID: 26239805
Item in Clipboard
Cite
Cite